Figure 2. Impact of TMPRSS2 and IFITMs on syncytia formation by U2OS‐ACE2‐infected cells.
-
ATMPRSS2 increases fusion and cell mortality. Right panel: Areas of GFP+ cells and nuclei count normalized to NI.
-
BIFITM1, but not IFITM2 and 3, inhibits SARS‐CoV‐2‐induced syncytia formation. Right panels: Area of GFP+ cells
-
CThe fusion of IFITM1+ cells with U2OS‐ACE2 syncytia is drastically reduced. Right panel: Area of IFITM+ GFP+ cells
-
DIFITM1 decreases the number of infected cells. Right panel: Fraction of cells positive for S, normalized to control cells (transduced with pQCXIP‐empty vector).
Data information: Left panels: one representative experiment is shown. Scale bars: 100 µm. Right panels: Data are mean ± SD of 3–9 independent experiments. Statistical analysis: B–C: One‐way ANOVA, D: Two‐way ANOVA. ns: non‐significant, *P < 0. 05, **P < 0.01, ***P < 0.001, ****P < 0.0001.